India  

Covid: Centre reassures Covishield’s safety, explains how to stop virus mutation

Video Credit: HT Digital Content - Duration: 09:51s - Published
Covid: Centre reassures Covishield’s safety, explains how to stop virus mutation

Covid: Centre reassures Covishield’s safety, explains how to stop virus mutation

NITI Aayog Member (Health) V K Paul said there is adequate supplies of vaccines for inoculating those aged 45 and above.

"We have seamless connection with states.

There is no inadequacy of vaccine supply," he said.

"Active participation of the private sector has been very important for us but still there is a great room for improvement," Paul said as he appealed to the private sector partners to come forward to participate in the inoculation drive.

Responding to a question on blood clotting post vaccination, Paul said the committee which closely monitor adverse events following immunisation has "concluded that thrombosis events due to Covishield in India is not a problem".

Watch the full video for more details.


You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Chhattisgarh will receive 3.50 lakh doses of Covishield today [Video]

Chhattisgarh will receive 3.50 lakh doses of Covishield today

Health Minister of Chhattisgarh, TS Singh Deo on May 08 said the state government will receive 3.50 lakh doses of Covishield today and the further vaccination will go on with this. "We received 1.50 lakh Covaxin doses from Bharat Biotech on May 1 and the vaccination is going on with that. We'll receive 3.50 lakh doses of Covishield today and the vaccination will further go on with this," Deo said media persons.

Credit: ANI    Duration: 01:25Published

US supplies of vaccine components to India to enable manufacturing of two crore doses of Covishield

The US on Wednesday said the vaccine components it has supplied to India this week will enable the manufacturing of two crore doses of the Covishield vaccine..
IndiaTimes
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."

Credit: ANI    Duration: 01:57Published

NITI Aayog NITI Aayog Indian government think tank

Foreign aid allocation 100% transparent, no delays: Kant

The Centre is following a transparent system for allocating all foreign aid being received to combat the surge in Covid-19 cases and all items received up to May..
IndiaTimes

Nationwide total lockdown amid rise in COVID-19 cases? Here's what the Centre said

NITI Aayog member Dr VK Paul said that the Centre has already given guidelines to the state governments on sanctions to break the chain of infection.
DNA
‘All options being discussed’: Govt on nationwide lockdown amid Covid crisis [Video]

‘All options being discussed’: Govt on nationwide lockdown amid Covid crisis

Responding to a question on whether nationwide lockdown is the only solution amid the rise in Covid cases, NITI Aayog member Doctor VK Paul said a detailed advisory has been issued to states and UTs to impose restrictions to break the chain of the virus. He said that states and UTs should make a careful analysis of the local situation and take the decision on lockdown. He added, “In addition to this range of restrictions, if anything more is required, those options are always being discussed and those decisions as required will be taken.” Watch the full video for more.

Credit: HT Digital Content    Duration: 02:13Published
All options get discussed: Govt on nationwide lockdown [Video]

All options get discussed: Govt on nationwide lockdown

Replying to a question whether a nationwide lockdown is the only solution amid the rise in COVID-19 cases, NITI Aayog member Doctor VK Paul on May 05 said, "If anything more is required those options are always being discussed. There's already a guideline to states to impose restrictions to suppress chain of transmission."

Credit: ANI    Duration: 02:21Published

Related videos from verified sources

Covid: Centre explains 5 steps discussed with States to curb virus spread [Video]

Covid: Centre explains 5 steps discussed with States to curb virus spread

Centre on Saturday spoke on the five steps discussed with the States that have high number of Covid-19 cases. Health Secretary Rajesh Bhushan said that Centre discussed the steps with States to curb..

Credit: HT Digital Content     Duration: 09:52Published